Abstract
To evaluate glucose metabolism and/or insulin resistance (IR) in 96 patients with Fibromyalgia (FM), associated or not to cognitive impairment. We investigated glucose metabolism in 96 FM patients. Enrolled patients were divided into two groups: 48 patients with memory deficit (group A) and 48 without memory deficit (control group). We evaluated glucose and insulin levels after a 2 h-Oral-Glucose-Tolerance-Test (2 h-OGTT) and insulin resistance (IR) by the homeostasis model assessment formula (HOMA). Body Mass Index (BMI), waist-to-hip-ratio (WHR), anxiety level, fasting plasma insulin and Non-Steroidal Anti-Inflammatory agents use were higher in patients with FM with memory impairment; while age, sex, waist circumference, education level, fasting plasma glucose, glycate hemoglobin, triglycerides, blood lipid profile, C- Reactivity-Protein (CRP), blood pressure and smoking habits were similar in both groups. Following OGTT the prevalence of glucose metabolism abnormalities was significantly higher in group A. IR was present in 79 % patients, of whom 23 % had also impaired glucose tolerance, 4 % newly diagnosed diabetes mellitus and 52 % IR only. Obesity and overweight prevailed in group A. IR, but not BMI or WHR was associated to an increased risk of memory impairment (OR = 2,6; 95 % CI: 1,22–3,7). The results of this study suggest that IR may represent a risk factor for memory impairment in fibromialgic patients.
Similar content being viewed by others
Abbreviations
- NGM:
-
Normal Glucose Metabolism
- IGT:
-
Impaired Glucose Tolerance
- NDDM:
-
Newly Diagnosed Diabetes Mellitus
- IR:
-
Insulin Resistance
References
American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, International Diabetes Federation (2007) Consensus statement on the world wide standardization on the HbA1c measurement. Diabetologia 50:2042–2043
Beck AT, Ward C, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
Bingham EM, Hopkins D, Smith D, Pernet A, Hallett W, Reed L, Marsden PK, Amiel SA (2002) The role of insulin in human brain glucose metabolism: an 18-fluoro-deoxyglucose positron emission tomography study. Diabetes 51:3384–3390
Blanchard JG, Duncan PM (1997) Effect of combinations of insulin, glucose and scopolamine on radial arm maze performance. Pharmacol Biochem Behav 58(1):209–214
Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M (1998) Prevalence of insulin resistance in metabolic disorders: the Bruneck study. Diabetes 47:1643–1649
Bosco D, Costa R, Plastino M, Branca D, Cotronei P, Santacroce N, Siniscalchi A, Consoli D, Ceccotti C, Mungari P, Fava A (2009) Glucose metabolism in the idiopathic blepharoptosis: utility of the oral glucose tolerance test (OGTT) and of the insulin resistance index. J Neurol Sci 284:24–28
Bosco D, Fava A, Plastino M, Montalcini T, Pujia A (2011) Possible implications of insulin resistance and glucose metabolism in Alzheimer’s disease pathogenesis. J Cell Mol Med 15(9):1807–1821
Cleeman JI (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). J Am Med Assoc 285(19):2486–2497
Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24:385–396
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of Diabetes Mellitus. Diabetes Care 26:S4–S20
Folstein MF, Folstein SE, Mc Hugh PR (1975) Mini mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Grace GM, Nielson WR, Hopkins M, Berg MA (1999) Concentration and memory deficits in patients with fibromyalgia syndrome. J Clin Exp Neuropsychol 21:477–487
Greisen J, Juhl CB, Grofte T, Vilstrup H, Jensen TS, Schmitz O (2001) Acute pain induces insulin resistance in humans. Anesthesiology 95:578–584
Jonides J (1995) Working memory and thinking. In: Smith EE, Osherson DN (eds) An invitation to cognitive science: thinking, vol 3. MIT Press, Cambridge, pp 215–265
Landro NI, Stiles TC, Sletvold H (1997) Memory functioning in patients with primary fibromyalgia and major depression and healthy controls. J Psychosom Res 42:297–306
Landsberg L (1999) Role of the sympathetic adrenal system in the pathogenesis of the insulin resistance syndrome. Ann NY Acad Sci 892:84–90
Laws A, Reaven GM (1993) Insulin resistance and risk factors for coronary heart disease. Bailliere’s Clin Endocrinol Metabol 7:1063–1078
Leavitt F, Katz RS (2006) Distraction as a key determinant of impaired memory in patients with fibromyalgia. J Rheumatol 33:127–132
Lee ZS, Critchley JA, Tomlinnson B, Young RP, Thomas GN, Cockram CS, Chan TY, Chan JC (2001) Urinary epinephrine and norepinephrine 3interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese. Metabolism 50:135–143
Lezak MD (1995) Neuropsychological assessment. Oxford University Press, New York, pp 333–335
Lipman RS (1982) Differentiating anxiety and depression in anxiety disorders: use of rating scale. Psychormacol Bull 18:69–77
Loevinger BL, Muller D, Alonso C, Coe CL (2007) Metabolic syndrome in women with chronic pain. Metabolism 56:87–93
Luchsinger JA, Tang MX, Shea S, Mayeux R (2004) Hyperinsulinemia and risk of Alzheimer’s disease. Neurology 63:1187–1192
Martinez-Lavin M, Hermosillo AG (2000) Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia. Semin Arthritis Rheum 29:197–199
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
Meenan RF, Mason JH, Anderson J, Guccione AA, Kazis LE (1992) AIMS2: the content and properties of a revised and expanded arthritis impact measurement scale health status questionnaire. Arthritis Rheum 35:1–10
Melzack R (1987) The short-form McGill pain questionnaire. Pain 30:191–197
Mersekey H, Bog-Duk N (1994) Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Monograph fort he task force of taxonomy, 2nd edn. International Association for the Study of Pain, Seattle, pp 45–47
Okifuji A, Bradshaw DH, Olson C (2009) Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions. Clin Reumatol 28:475–478
Ott A, Stolk RP, Van Harskamp F, Pols HA, Hofman A, Breteler MM (1999) Diabetes mellitus and the risk of dementia: the Rotterdarm Study. Neurology 53:1937–1942
Park DC, Smith AD, Lautenschlager G, Earles JL, Frieske D, Zwahr M, Gaines CL (1996) Mediators of long-term memory performance across the life span. Psychol Aging 22:137–142
Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM (1998) The revised piper fatigue scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25:677–684
Pi-Sunyer FX (2000) Obesity: criteria and classification. Proc Nutr Soc 59:505–509
Plastino M, Fava A, Pirritano D, Cotronei P, Sacco N, Sperlì T, Spanò A, Gallo D, Mungari P, Consoli D, Bosco D (2010) Effects of insulin therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2. J Neurol Sci 288:112–116
Suhr JA (2003) Neuropsychological impairment in fibromyalgia: relation to depression, fatigue and pain. J Psychosom Res 55:321–329
Svetvold H, Stiles TC, Landro NI (1995) Information processing in primary fibromyalgia, major depression and healthy controls. J Rheumatol 22:137–142
Talbot K, Wang H-Y, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE (2012) Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation and cognitive decline. J Clin Investig 122:1316–1338
Tewes U (1991) Handbuch and Testanweisungen fur den Hamburg-Wechsler Intelligenztest fur Erwachesene Revision
Tsigos C, Chrousos GP (2004) Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 57:451–458
Uchida I, Asoh T, Shirasaka C, Tsuji H (1988) Effect of epidural analgesia on postoperative insulin resistance as evaluated by insulin clamp technique. Br J Surg 75:557–562
Wallitt B, Roebuck-Spencer T, Bleiberg J, Forster G, Weinstein A (2008) Automated neuropsychiatric measurements of information processing in fibromyalgia. Reumathol Int 28:561–566
Watson GS, Bernhardt T, Reger MA, Chorleton BA, Baker LD, Peskind ER, Asthana S, Plymate SR, Frolich L, Craft S (2006) Insulin effects on CSF norepinephrine and cognition in Alzheimer disease. Neurobiol Aging 27:38–41
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P (1990) The American College of Rheumatology criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172
Wolfe F, Ross K, Anderson J, Russell IJ (1995) Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 22:151–156
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 62:600–610
Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L (2004) Diabetes mellitus and risk of dementia in the Kungshol men project: a 6-year follow-up study. Neurology 63:1181–1186
Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292:2237–2242
Yanmaz MN, Mert M, Korkmaz M (2011) The prevalence of fibromyalgia syndrome in a group of patients with diabetes mellitus. Rheumatol Int 8:1018–1022
Yesavage JA, Brink TL (1983) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37–49
Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC (1992) Plasma and urinary catecholamines in primary fibromyalgia: a controlled study. J Rheumatol 19:95–97
Ziemus B, Baumann O, Luerding R, Schlosser R, Schuierer G, Bogdahn U, Greenlee MW (2007) Impaired working-memory after cerebellar infarcts paralleled by changes in BOLD signal of a cortico-cerebellar circuit. Neuropsychologia 45:2016–2024
Disclosure
All authors have declared “no conflict of interest”.
Author roles
Fava Antonietta and Bosco Domenico: design, conduct of the study, data collection, analysis; Massimiliano Plastino, Dario Cristiano, Domenico Pirritano: conduct of the study, data collection; Antonio Spanò, Carlo Opipari, Stefano Cristofaro, Antonio Chillà, Matteo De Bartolo: data collection; Fatima Casalinuovo and Carmen Colica: data collection and analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fava, A., Plastino, M., Cristiano, D. et al. Insulin resistance possible risk factor for cognitive impairment in fibromialgic patients. Metab Brain Dis 28, 619–627 (2013). https://doi.org/10.1007/s11011-013-9421-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-013-9421-3